Added to YB: 2025-03-26
Pitch date: 2025-02-05
CRL [bullish]
Charles River Laboratories International, Inc.
+15.46%
current return
Author Info
No bio for this author
Company Info
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Market Cap
$7.0B
Pitch Price
$167.18
Price Target
300.00 (+55%)
Dividend
N/A
EV/EBITDA
10.22
P/E
-232.20
EV/Sales
2.45
Sector
Life Sciences Tools and Services
Category
value
Charles River Laboratories International, Inc. - $CRL
CRL: #1 in safety assessment, 60% off highs. Preclinical slowdown & NHP supply issues create opportunity. 14x fwd EBITDA historically, now cheaper. $300 PT by 2027 (~20% IRR). Risks: prolonged R&D cuts, NIH funding, CDMO issues. Catalysts: organic growth return, capital return, M&A.
Read full article (8 min)